107 related articles for article (PubMed ID: 1831044)
1. Two- and three-dimensional proton NMR studies of apo-neocarzinostatin.
Gao XL; Burkhart W
Biochemistry; 1991 Aug; 30(31):7730-9. PubMed ID: 1831044
[TBL] [Abstract][Full Text] [Related]
2. Assignment of the protonated 13C resonances of apo-neocarzinostatin by 2D heteronuclear NMR spectroscopy at natural abundance.
Lefevre C; Adjadj E; Quiniou E; Mispelter J
J Biomol NMR; 1994 Sep; 4(5):689-702. PubMed ID: 7919954
[TBL] [Abstract][Full Text] [Related]
3. Sequential 1H NMR assignments and secondary structure of aponeocarzinostatin in solution.
Remerowski ML; Glaser SJ; Sieker LC; Samy TS; Drobny GP
Biochemistry; 1990 Sep; 29(36):8401-9. PubMed ID: 2147566
[TBL] [Abstract][Full Text] [Related]
4. Proton NMR studies of apo-neocarzinostatin from Streptomyces carzinostaticus. Sequence-specific assignment and secondary structure.
Adjadj E; Mispelter J; Quiniou E; Dimicoli JL; Favaudon V; Lhoste JM
Eur J Biochem; 1990 Jun; 190(2):263-71. PubMed ID: 2142075
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of apo-neocarzinostatin at 0.15-nm resolution.
Teplyakov A; Obmolova G; Wilson K; Kuromizu K
Eur J Biochem; 1993 Apr; 213(2):737-41. PubMed ID: 8477746
[TBL] [Abstract][Full Text] [Related]
6. Three-dimensional solution structure of apo-neocarzinostatin.
Gao X
J Mol Biol; 1992 May; 225(1):125-35. PubMed ID: 1533878
[TBL] [Abstract][Full Text] [Related]
7. Key interactions in the immunoglobulin-like structure of apo-neocarzinostatin: evidence from nuclear magnetic resonance relaxation data and molecular dynamics simulations.
Izadi-Pruneyre N; Quiniou E ; Blouquit Y; Perez J; Minard P; Desmadril M; Mispelter J; Adjadj E
Protein Sci; 2001 Nov; 10(11):2228-40. PubMed ID: 11604530
[TBL] [Abstract][Full Text] [Related]
8. Three-dimensional solution structure of apo-neocarzinostatin from Streptomyces carzinostaticus determined by NMR spectroscopy.
Adjadj E; Quiniou E; Mispelter J; Favaudon V; Lhoste JM
Eur J Biochem; 1992 Feb; 203(3):505-11. PubMed ID: 1531194
[TBL] [Abstract][Full Text] [Related]
9. Sequential 1H NMR assignment of the complex of aponeocarzinostatin with ethidium bromide and investigation of protein-drug interactions in the chromophore binding site.
Mohanty S; Sieker LC; Drobny GP
Biochemistry; 1994 Sep; 33(35):10579-90. PubMed ID: 8075058
[TBL] [Abstract][Full Text] [Related]
10. The seven-stranded beta-barrel structure of apo-neocarzinostatin as compared to the immunoglobulin domain.
Adjadj E; Quiniou E; Mispelter J; Favaudon V; Lhoste JM
Biochimie; 1992; 74(9-10):853-8. PubMed ID: 1334698
[TBL] [Abstract][Full Text] [Related]
11. Design, production, and characterization of recombinant neocarzinostatin apoprotein in Escherichia coli.
Nozaki S; Tomioka Y; Hishinuma T; Inoue M; Nagumo Y; Tsuruta LR; Hayashi K; Matsumoto T; Kato Y; Ishiwata S; Itoh K; Suzuki T; Hirama M; Mizugaki M
J Biochem; 2002 May; 131(5):729-38. PubMed ID: 11983081
[TBL] [Abstract][Full Text] [Related]
12. Solution structure of a novel chromoprotein derived from apo-neocarzinostatin and a synthetic chromophore.
Urbaniak MD; Muskett FW; Finucane MD; Caddick S; Woolfson DN
Biochemistry; 2002 Oct; 41(39):11731-9. PubMed ID: 12269815
[TBL] [Abstract][Full Text] [Related]
13. Neocarzinostatin: selective tryptophan oxidation and neocarzinostatin-chromophore binding to apo-neocarzinostatin.
Edo K; Saito K; Matsuda Y; Akiyama-Murai Y; Mizugaki M; Koide Y; Ishida N
Chem Pharm Bull (Tokyo); 1991 Jan; 39(1):170-6. PubMed ID: 1828722
[TBL] [Abstract][Full Text] [Related]
14. An antitumor polypeptide antibiotic neocarzinostatin: the mode of apo-protein--chromophore interaction.
Edo K; Saito K; Akiyama-Murai Y; Mizugaki M; Koide Y; Ishida N
J Antibiot (Tokyo); 1988 Apr; 41(4):554-62. PubMed ID: 2967272
[TBL] [Abstract][Full Text] [Related]
15. Characterization of secondary structure of neocarzinostatin apoprotein.
Saito K; Sato Y; Edo K; Akiyama-Murai Y; Koide Y; Ishida N; Mizugaki M
Chem Pharm Bull (Tokyo); 1989 Nov; 37(11):3078-82. PubMed ID: 2534360
[TBL] [Abstract][Full Text] [Related]
16. Synthetic ligands for apo-neocarzinostatin.
Caddick S; Muskett FW; Stoneman RG; Woolfson DN
J Am Chem Soc; 2006 Apr; 128(13):4204-5. PubMed ID: 16568976
[TBL] [Abstract][Full Text] [Related]
17. Structural comparison of apomyoglobin and metaquomyoglobin: pH titration of histidines by NMR spectroscopy.
Cocco MJ; Kao YH; Phillips AT; Lecomte JT
Biochemistry; 1992 Jul; 31(28):6481-91. PubMed ID: 1633160
[TBL] [Abstract][Full Text] [Related]
18. Sequential 1H, 13C, and 15N NMR assignments and solution conformation of apokedarcidin.
Constantine KL; Colson KL; Wittekind M; Friedrichs MS; Zein N; Tuttle J; Langley DR; Leet JE; Schroeder DR; Lam KS
Biochemistry; 1994 Sep; 33(38):11438-52. PubMed ID: 7918358
[TBL] [Abstract][Full Text] [Related]
19. Two-dimensional NMR studies of squash family inhibitors. Sequence-specific proton assignments and secondary structure of reactive-site hydrolyzed Cucurbita maxima trypsin inhibitor III.
Krishnamoorthi R; Gong YX; Lin CL; VanderVelde D
Biochemistry; 1992 Jan; 31(3):898-904. PubMed ID: 1731946
[TBL] [Abstract][Full Text] [Related]
20. A study of the interactions between residues in the C-terminal half of calmodulin by one and two-dimensional NMR methods and computer modelling.
Aulabaugh A; Niemczura WP; Blundell TL; Gibbons WA
Eur J Biochem; 1984 Sep; 143(2):409-18. PubMed ID: 6088236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
